Accelerating NDA filing through faster carcinogenicity assessment
Drug Discovery World
MAY 10, 2023
Due to the high costs associated with new drug development, pharmaceutical companies are under pressure to get effective drugs to market as fast as possible while ensuring they are safe for the intended patient population and dosing timeline, which can be lifelong for some drugs. billion and take over 10 years.
52 
Let's personalize your content